Cargando…
Expression, Purification and Characterization of Functional Teduglutide Using GST Fusion System in Prokaryotic Cells
PURPOSE: Teduglutide is the first and only FDA-approved drug for long-term treatment of short bowel syndrome (SBS). The current study aimed to present an approach for production of teduglutide using recombinant DNA technology. METHODS: The coding gene for teduglutide was cloned into pGEX-2T vector,...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Tabriz University of Medical Sciences
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460804/ https://www.ncbi.nlm.nih.gov/pubmed/37646058 http://dx.doi.org/10.34172/apb.2023.064 |